Related Experiment Video
Updated: Oct 16, 2025

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
Promiscuous Structural Variants Drive Myeloma Initiation and Progression.
P Leif Bergsagel1, W Michael Kuehl2
1Department of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona.
This study reveals that structural genomic variants, particularly involving the immunoglobulin heavy chain and MYC loci, drive multiple myeloma initiation and progression. It also uncovers numerous genomic factors contributing to the disease's complexity.
Area of Science:
- Genomics
- Cancer Biology
- Hematology
Background:
- Multiple myeloma is a hematologic malignancy characterized by genomic complexity.
- Understanding structural variants is crucial for elucidating disease mechanisms.
Purpose of the Study:
- To conduct a comprehensive genomic analysis of structural variants in multiple myeloma.
- To identify key genomic alterations and mechanisms contributing to disease heterogeneity.
Main Methods:
- Genomic analysis of structural variants.
- Identification of genomic hotspots, oncogenes, and tumor suppressor genes.
- Investigation of recombination mechanisms.
Main Results:
- Structural variants involving the immunoglobulin heavy chain locus are critical for multiple myeloma initiation.
- Alterations at the MYC locus are associated with disease progression.
- Multiple myeloma exhibits significant genomic heterogeneity due to numerous contributing factors.
Conclusions:
- Structural genomic events play a pivotal role in multiple myeloma pathogenesis.
- The complexity of multiple myeloma arises from a combination of genomic hotspots, oncogenes, tumor suppressor genes, and recombination mechanisms.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Spontaneous and Induced Mutations
Induced Pluripotent Stem Cells
Somatic...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Differentiation of Common Myeloid Progenitor Cells

